陳 威穎

Medicine & Life Sciences

1. Helicobacter pylori 100%
2. Peptic Ulcer 98%
3. Esomeprazole 88%
4. Pylorus 78%
5. Peptic Esophagitis 71%
6. Hemorrhage 55%
7. Los Angeles 49%
8. Ulcer 44%
9. Stomach 43%
10. Life Expectancy 38%
11. Endoscopic Hemostasis 35%
12. Levofloxacin 33%
13. Stomach Ulcer 33%
14. Stomach Neoplasms 29%
15. Proton Pump Inhibitors 29%
16. Omeprazole 27%
17. Helicobacter Infections 24%
18. Endoscopy 24%
19. Pantoprazole 20%
20. Adenocarcinoma 20%
21. Bismuth 19%
22. Esophageal Mucosa 18%
23. Clarithromycin 18%
24. Equivalence Trials 18%
25. Tranexamic Acid 18%
26. Therapeutics 17%
27. Hypoalbuminemia 17%
28. Comorbidity 17%
29. Matrix Metalloproteinase 1 17%
30. Matrix Metalloproteinase Inhibitors 16%
31. Tissue Inhibitor of Metalloproteinase-1 16%
32. Metaplasia 16%
33. Overweight 16%
34. Dyspepsia 16%
35. Breath Tests 14%
36. Body Mass Index 14%
37. Quality-Adjusted Life Years 13%
38. Neoplasms 13%
39. Intravenous Infusions 13%
40. Matrix Metalloproteinase 7 13%
41. Abscess 12%
42. Colorectal Neoplasms 12%
43. Biliary Tract Diseases 12%
44. Albumins 11%
45. Longitudinal Studies 11%